Nixon Peabody Trust’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-4,700
Closed -$337K 77
2018
Q1
$337K Sell
4,700
-2,425
-34% -$175K 0.3% 58
2017
Q4
$538K Sell
7,125
-150
-2% -$11K 0.46% 52
2017
Q3
$530K Sell
7,275
-100
-1% -$7.21K 0.48% 53
2017
Q2
$546K Sell
7,375
-125
-2% -$9.28K 0.51% 55
2017
Q1
$549K Sell
7,500
-800
-10% -$56K 0.52% 54
2016
Q4
$543K Hold
8,300
0.53% 55
2016
Q3
$615K Sell
8,300
-155
-2% -$11.5K 0.6% 54
2016
Q2
$619K Sell
8,455
-85
-1% -$6.05K 0.54% 61
2016
Q1
$603K Sell
8,540
-30
-0.4% -$2K 0.54% 62
2015
Q4
$571K Buy
+8,570
New +$570K 0.52% 63

Other funds holding CL

Nixon Peabody Trust's CL Position: Q2 2018 in Review

Nixon Peabody Trust sold out of Colgate-Palmolive (CL) in Q2 2018, closing a stake of 4,700 shares — an estimated $337K sold.

Nixon Peabody Trust first reported a position in CL in Q4 2015 and held it in 10 quarters. The position peaked at $619K in Q2 2016. 1,417 funds tracked by Wall St. Rank hold CL as of Q2 2018.

  • Nixon Peabody Trust reported no remaining Colgate-Palmolive position as of Q2 2018 after selling out during the quarter.
  • Nixon Peabody Trust sold 4,700 Colgate-Palmolive shares in Q2 2018, an estimated $337K.
  • Nixon Peabody Trust first reported a position in Colgate-Palmolive in Q4 2015 and held it in 10 quarters.
  • Nixon Peabody Trust's Colgate-Palmolive position peaked at $619K in Q2 2016.
  • 1,417 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2018.

Based on Nixon Peabody Trust's 13F filing for Q2 2018, filed 30 Jul 2018.